Intellia Therapeutics, Inc. (NTLA)
13.38
+0.62
(+4.86%)
USD |
NASDAQ |
Mar 16, 16:00
13.30
-0.08
(-0.60%)
Pre-Market: 08:52
Intellia Therapeutics Profit Margin (Quarterly) : -416.2% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -- |
| Recursion Pharmaceuticals, Inc. | -304.2% |
| Personalis, Inc. | -137.3% |
| Regeneron Pharmaceuticals, Inc. | 21.74% |
| Pacific Biosciences of California, Inc. | -90.43% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -54.49% |
| Return on Assets | -42.60% |
| Return on Invested Capital | -46.79% |
| Gross Profit Margin (Quarterly) | 73.87% |
| Operating Margin (Quarterly) | -428.9% |
| Return on Net Operating Assets | -225.5% |